Nicholas Investment Partners, LP

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1389574 RANCHO SANTA FE, CA

Position in XENE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$14,368,923

+$3,478,157 QoQ

Shares Held

247,101

+1.7% QoQ

Ownership

0.256%

of shares outstanding

% of Portfolio

1.20%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Nicholas Investment Partners, LP holds $224,688,311 across 27 Biotechnology names. XENE ranks #5 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	182,540	$29,848,940
2	RVMD	Revolution Medicines, Inc.	261,166	$25,398,393
3	BBIO	BridgeBio Pharma, Inc.	298,909	$22,196,982
4	NUVL	Nuvalent, Inc.	159,721	$16,363,416
5	XENE	Xenon Pharmaceuticals Inc. This page	247,101	$14,368,923
6	AXSM	Axsome Therapeutics, Inc.	81,478	$13,771,411
7	MIRM	Mirum Pharmaceuticals, Inc.	131,303	$12,129,771
8	APGE	Apogee Therapeutics, Inc.	130,992	$11,025,596

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$14,368,923	247,101	+1.7%	Shares	Sole	2026-05-15
2025-12-31	$10,890,766	242,989	+104.0%	Shares	Sole	2026-02-13
2025-09-30	$4,781,784	119,098	+72.9%	Shares	Sole	2025-11-14
2025-06-30	$2,156,444	68,896	-20.8%	Shares	Sole	2025-08-14
2025-03-31	$2,917,776	86,968	+493.3%	Shares	Sole	2025-05-15
2024-12-31	$574,593	14,658	0.0%	Shares	Sole	2025-02-14
2024-09-30	$577,085	14,658	-91.3%	Shares	Sole	2024-11-12
2024-03-31	$7,229,214	167,926	+91.4%	Shares	Sole	2024-05-14
2023-12-31	$4,041,857	87,752	-89.7%	Shares	Sole	2024-02-08
2023-09-30	$29,187,909	854,447	+8.0%	Shares	Sole	2023-11-13
2023-06-30	$30,458,043	791,118	+81.2%	Shares	Sole	2023-08-10
2023-03-31	$15,630,029	436,715	+73.1%	Shares	Sole	2023-05-12
2022-12-31	$9,948,267	252,302	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.